Therefore, distinct patterns of CD39 and CD103 expression describe tumor-reactive CTLs (CD8+/CD39+/CD103+) and tumor infiltrating Tregs (CD4+/CD39+/CD103−). This evidence concerns the gene CD4 and neoplasm.